US Stock MarketDetailed Quotes

BMRN Biomarin Pharmaceutical

Watchlist
  • 63.690
  • +0.410+0.65%
Close Apr 30 16:00 ET
  • 63.690
  • 0.0000.00%
Post 20:01 ET
12.21BMarket Cap28.82P/E (TTM)

Biomarin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
259.69%572.84M
575.42%185.63M
63.28%221.48M
69.51%118.76M
163.53%46.97M
-9.46%159.26M
305.00%27.48M
-14.32%135.65M
24.61%70.06M
-62.73%-73.93M
Net income from continuing operations
154.62%426.86M
513.22%124.94M
162.72%106.08M
91.25%107.17M
74.35%88.66M
18.43%167.65M
8,282.73%20.38M
707.01%40.38M
102.57%56.04M
-57.90%50.85M
Operating gains losses
-194.05%-26.75M
-75.65%5.6M
-19.64%-2.39M
-1,189.76%-9.15M
-414.50%-20.8M
123.26%28.45M
1,185.91%22.99M
46.53%-2M
115.42%840K
105.76%6.62M
Depreciation and amortization
-7.63%96.43M
-12.11%23.61M
-26.00%19.01M
4.11%26.46M
3.52%27.35M
2.37%104.39M
9.40%26.86M
3.56%25.69M
0.59%25.42M
-3.37%26.42M
Deferred tax
224.71%56.1M
270.61%42.39M
180.99%12.17M
0.00%1.25M
104.48%285K
13.64%-44.98M
51.61%-24.84M
-258.00%-15.03M
193.09%1.25M
-232.50%-6.36M
Other non cash items
514.54%23.49M
2,497.06%22.05M
-41.98%322K
-99.63%6K
38.41%1.12M
1.19%3.82M
199.41%849K
-55.60%555K
574.12%1.61M
-78.32%807K
Change In working capital
35.70%-216.4M
14.38%-83.15M
-2.15%39.06M
-6.73%-66.92M
51.35%-105.39M
-249.17%-336.54M
-638.86%-97.12M
-56.39%39.92M
-64.68%-62.7M
-58.49%-216.64M
-Change in receivables
69.59%-57.91M
224.02%72.55M
-635.42%-74.38M
-649.04%-52.7M
97.56%-3.39M
-132.14%-190.44M
-106.83%-58.5M
-64.21%13.89M
81.36%-7.04M
-153.22%-138.8M
-Change in inventory
59.55%-63.53M
42.02%-34.27M
143.76%18.15M
27.82%-30.59M
-19.31%-16.82M
-130.07%-157.06M
-44.72%-59.11M
-59.58%-41.47M
-1,557.98%-42.38M
-1,353.16%-14.1M
-Change in payables and accrued expense
-146.82%-32.24M
-900.79%-100.26M
50.17%122.28M
-28.03%4.75M
-86.22%-59.01M
16.66%68.85M
-79.61%12.52M
10.11%81.43M
266.69%6.59M
59.45%-31.69M
-Change in other current assets
4.92%-77.48M
-1,903.12%-25.7M
-44.24%-30.51M
136.17%8.22M
18.83%-29.48M
-576.95%-81.48M
91.79%-1.28M
-428.80%-21.16M
-710.97%-22.72M
-452.79%-36.32M
-Change in other current liabilities
-37.41%14.76M
-51.02%4.53M
-51.31%3.52M
19.63%3.4M
-22.36%3.31M
240.18%23.59M
-9.16%9.25M
531.32%7.23M
186.49%2.84M
149.24%4.26M
Cash from discontinued investing activities
Operating cash flow
259.69%572.84M
575.42%185.63M
63.28%221.48M
69.51%118.76M
163.53%46.97M
-9.46%159.26M
305.00%27.48M
-14.32%135.65M
24.61%70.06M
-62.73%-73.93M
Investing cash flow
Cash flow from continuing investing activities
222.70%136.49M
217.61%76.4M
64.72%-16.16M
206.40%90.48M
52.57%-14.24M
-455.41%-111.24M
-18.74%-64.96M
-95.71%-45.8M
199.43%29.53M
-134.19%-30.01M
Net PPE purchase and sale
11.65%-85.42M
32.46%-19.53M
15.05%-18.46M
1.19%-21.33M
-6.74%-26.1M
20.06%-96.69M
18.97%-28.92M
25.82%-21.74M
20.52%-21.58M
15.13%-24.46M
Net intangibles purchase and sale
-9.84%-11.99M
90.11%-769K
-61.10%-2.71M
55.36%-512K
-2,480.65%-8M
-3.20%-10.92M
-1,059.31%-7.78M
76.52%-1.68M
-30.19%-1.15M
83.32%-310K
Net investment purchase and sale
6,231.79%222.77M
442.11%96.7M
117.33%3.88M
114.92%112.32M
288.11%9.87M
-144.38%-3.63M
-142.09%-28.27M
-271.24%-22.38M
3,240.63%52.26M
-162.03%-5.25M
Net other investing changes
--11.14M
--0
--1.14M
--0
--10M
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
222.70%136.49M
217.61%76.4M
64.72%-16.16M
206.40%90.48M
52.57%-14.24M
-455.41%-111.24M
-18.74%-64.96M
-95.71%-45.8M
199.43%29.53M
-134.19%-30.01M
Financing cash flow
Cash flow from continuing financing activities
-2,711.17%-526.45M
-73.63%2.86M
-63,240.74%-499.13M
5.43%12.61M
-5.03%-42.79M
-0.41%-18.73M
-0.27%10.84M
-110.45%-788K
201.55%11.96M
-61.16%-40.74M
Net issuance payments of debt
---494.99M
--0
-30,370.76%-494.93M
97.10%-18K
95.86%-42K
--0
--0
418.71%1.64M
-11.69%-621K
-79.15%-1.01M
Proceeds from stock option exercised by employees
-28.95%49.28M
-46.90%7.86M
10.15%4.8M
1.37%29.42M
-66.00%7.2M
0.03%69.35M
-41.87%14.81M
-69.70%4.36M
36.53%29.02M
157.06%21.17M
Net other financing activities
8.34%-80.74M
-26.18%-5M
-32.71%-9M
-2.14%-16.79M
17.98%-49.95M
-0.11%-88.08M
75.57%-3.97M
-7.26%-6.78M
49.39%-16.44M
-84.82%-60.9M
Cash from discontinued financing activities
Financing cash flow
-2,711.17%-526.45M
-73.63%2.86M
-63,240.74%-499.13M
5.43%12.61M
-5.03%-42.79M
-0.41%-18.73M
-0.27%10.84M
-110.45%-788K
201.55%11.96M
-61.16%-40.74M
Net cash flow
Beginning cash position
4.22%755.13M
-14.00%675.45M
40.00%972.15M
28.78%747M
4.22%755.13M
23.37%724.53M
3.14%785.41M
12.03%694.38M
-4.19%580.07M
23.37%724.53M
Current changes in cash
524.44%182.89M
1,094.33%264.89M
-429.89%-293.8M
98.87%221.85M
93.05%-10.06M
-78.66%29.29M
28.11%-26.64M
-37.48%89.06M
656.46%111.56M
-947.55%-144.69M
Effect of exchange rate changes
269.27%4.83M
168.66%2.5M
-246.96%-2.9M
19.91%3.3M
741.48%1.93M
3,987.50%1.31M
-5,236.62%-3.65M
364.26%1.97M
814.81%2.75M
-79.05%229K
End cash Position
24.86%942.84M
24.86%942.84M
-14.00%675.45M
40.00%972.15M
28.78%747M
4.22%755.13M
4.22%755.13M
3.14%785.41M
12.03%694.38M
-4.19%580.07M
Free cash flow
820.51%475.42M
1,894.51%165.33M
78.48%200.31M
104.77%96.92M
113.04%12.87M
16.42%51.65M
68.85%-9.21M
-7.90%112.23M
67.90%47.33M
-29.68%-98.7M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 259.69%572.84M575.42%185.63M63.28%221.48M69.51%118.76M163.53%46.97M-9.46%159.26M305.00%27.48M-14.32%135.65M24.61%70.06M-62.73%-73.93M
Net income from continuing operations 154.62%426.86M513.22%124.94M162.72%106.08M91.25%107.17M74.35%88.66M18.43%167.65M8,282.73%20.38M707.01%40.38M102.57%56.04M-57.90%50.85M
Operating gains losses -194.05%-26.75M-75.65%5.6M-19.64%-2.39M-1,189.76%-9.15M-414.50%-20.8M123.26%28.45M1,185.91%22.99M46.53%-2M115.42%840K105.76%6.62M
Depreciation and amortization -7.63%96.43M-12.11%23.61M-26.00%19.01M4.11%26.46M3.52%27.35M2.37%104.39M9.40%26.86M3.56%25.69M0.59%25.42M-3.37%26.42M
Deferred tax 224.71%56.1M270.61%42.39M180.99%12.17M0.00%1.25M104.48%285K13.64%-44.98M51.61%-24.84M-258.00%-15.03M193.09%1.25M-232.50%-6.36M
Other non cash items 514.54%23.49M2,497.06%22.05M-41.98%322K-99.63%6K38.41%1.12M1.19%3.82M199.41%849K-55.60%555K574.12%1.61M-78.32%807K
Change In working capital 35.70%-216.4M14.38%-83.15M-2.15%39.06M-6.73%-66.92M51.35%-105.39M-249.17%-336.54M-638.86%-97.12M-56.39%39.92M-64.68%-62.7M-58.49%-216.64M
-Change in receivables 69.59%-57.91M224.02%72.55M-635.42%-74.38M-649.04%-52.7M97.56%-3.39M-132.14%-190.44M-106.83%-58.5M-64.21%13.89M81.36%-7.04M-153.22%-138.8M
-Change in inventory 59.55%-63.53M42.02%-34.27M143.76%18.15M27.82%-30.59M-19.31%-16.82M-130.07%-157.06M-44.72%-59.11M-59.58%-41.47M-1,557.98%-42.38M-1,353.16%-14.1M
-Change in payables and accrued expense -146.82%-32.24M-900.79%-100.26M50.17%122.28M-28.03%4.75M-86.22%-59.01M16.66%68.85M-79.61%12.52M10.11%81.43M266.69%6.59M59.45%-31.69M
-Change in other current assets 4.92%-77.48M-1,903.12%-25.7M-44.24%-30.51M136.17%8.22M18.83%-29.48M-576.95%-81.48M91.79%-1.28M-428.80%-21.16M-710.97%-22.72M-452.79%-36.32M
-Change in other current liabilities -37.41%14.76M-51.02%4.53M-51.31%3.52M19.63%3.4M-22.36%3.31M240.18%23.59M-9.16%9.25M531.32%7.23M186.49%2.84M149.24%4.26M
Cash from discontinued investing activities
Operating cash flow 259.69%572.84M575.42%185.63M63.28%221.48M69.51%118.76M163.53%46.97M-9.46%159.26M305.00%27.48M-14.32%135.65M24.61%70.06M-62.73%-73.93M
Investing cash flow
Cash flow from continuing investing activities 222.70%136.49M217.61%76.4M64.72%-16.16M206.40%90.48M52.57%-14.24M-455.41%-111.24M-18.74%-64.96M-95.71%-45.8M199.43%29.53M-134.19%-30.01M
Net PPE purchase and sale 11.65%-85.42M32.46%-19.53M15.05%-18.46M1.19%-21.33M-6.74%-26.1M20.06%-96.69M18.97%-28.92M25.82%-21.74M20.52%-21.58M15.13%-24.46M
Net intangibles purchase and sale -9.84%-11.99M90.11%-769K-61.10%-2.71M55.36%-512K-2,480.65%-8M-3.20%-10.92M-1,059.31%-7.78M76.52%-1.68M-30.19%-1.15M83.32%-310K
Net investment purchase and sale 6,231.79%222.77M442.11%96.7M117.33%3.88M114.92%112.32M288.11%9.87M-144.38%-3.63M-142.09%-28.27M-271.24%-22.38M3,240.63%52.26M-162.03%-5.25M
Net other investing changes --11.14M--0--1.14M--0--10M--------------------
Cash from discontinued investing activities
Investing cash flow 222.70%136.49M217.61%76.4M64.72%-16.16M206.40%90.48M52.57%-14.24M-455.41%-111.24M-18.74%-64.96M-95.71%-45.8M199.43%29.53M-134.19%-30.01M
Financing cash flow
Cash flow from continuing financing activities -2,711.17%-526.45M-73.63%2.86M-63,240.74%-499.13M5.43%12.61M-5.03%-42.79M-0.41%-18.73M-0.27%10.84M-110.45%-788K201.55%11.96M-61.16%-40.74M
Net issuance payments of debt ---494.99M--0-30,370.76%-494.93M97.10%-18K95.86%-42K--0--0418.71%1.64M-11.69%-621K-79.15%-1.01M
Proceeds from stock option exercised by employees -28.95%49.28M-46.90%7.86M10.15%4.8M1.37%29.42M-66.00%7.2M0.03%69.35M-41.87%14.81M-69.70%4.36M36.53%29.02M157.06%21.17M
Net other financing activities 8.34%-80.74M-26.18%-5M-32.71%-9M-2.14%-16.79M17.98%-49.95M-0.11%-88.08M75.57%-3.97M-7.26%-6.78M49.39%-16.44M-84.82%-60.9M
Cash from discontinued financing activities
Financing cash flow -2,711.17%-526.45M-73.63%2.86M-63,240.74%-499.13M5.43%12.61M-5.03%-42.79M-0.41%-18.73M-0.27%10.84M-110.45%-788K201.55%11.96M-61.16%-40.74M
Net cash flow
Beginning cash position 4.22%755.13M-14.00%675.45M40.00%972.15M28.78%747M4.22%755.13M23.37%724.53M3.14%785.41M12.03%694.38M-4.19%580.07M23.37%724.53M
Current changes in cash 524.44%182.89M1,094.33%264.89M-429.89%-293.8M98.87%221.85M93.05%-10.06M-78.66%29.29M28.11%-26.64M-37.48%89.06M656.46%111.56M-947.55%-144.69M
Effect of exchange rate changes 269.27%4.83M168.66%2.5M-246.96%-2.9M19.91%3.3M741.48%1.93M3,987.50%1.31M-5,236.62%-3.65M364.26%1.97M814.81%2.75M-79.05%229K
End cash Position 24.86%942.84M24.86%942.84M-14.00%675.45M40.00%972.15M28.78%747M4.22%755.13M4.22%755.13M3.14%785.41M12.03%694.38M-4.19%580.07M
Free cash flow 820.51%475.42M1,894.51%165.33M78.48%200.31M104.77%96.92M113.04%12.87M16.42%51.65M68.85%-9.21M-7.90%112.23M67.90%47.33M-29.68%-98.7M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Market Insights

Inverse ETF Inverse ETF
No. Symbol Turnover
Sample Name
Sample Code
 4.42B
Sample Name
Sample Code
 1.69B
Sample Name
Sample Code
 640.24M
4
ProShares UltraPro Short S&P500 ETF
SPXU
602.98M
5
Tradr 2X Short TSLA Daily ETF
TSLQ
563.61M
Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 166.690
Sample Name
Sample Code
 97.350
Sample Name
Sample Code
 374.980
4
Qualcomm
QCOM
148.460
5
Cisco
CSCO
57.730
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 12.480
Sample Name
Sample Code
 0.6990
Sample Name
Sample Code
 3.544
4
Bitfarms
BITF
0.9989
5
FRMO CORP
FRMO
8.490
Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -